Search Results - "glucagon"

CLINICIANS' SELF-REPORTED EFFICACY IN CARDIOVASCULAR PREVENTION PRACTICE IN THE SOUTHEASTERN UNITED STATES by Trevor Caldarera, Megha Penmetsa, Austin Seals, Edward H. Ip, Salim S. Virani, Michael D. Shapiro, Yashashwi Pokharel

Connect to this object online.

Cost–benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand by Deerochanawong C, Kosachunhanun N, Gadekar AV, Chotikanokrat P, Permsuwan U

Connect to this object online.

Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel synd... by Chen KS, Xie J, Tang W, Zhao J, Jeppesen PB, Signorovitch JE

Connect to this object online.

Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers by Sok Cin Tye, Sieta T. de Vries, Johannes F. E. Mann, Johannes F. E. Mann, Meir Schechter, Meir Schechter, Ofri Mosenzon, Ofri Mosenzon, Petra Denig, Hiddo J. L. Heerspink

Connect to this object online.

Allspice and Clove As Source of Triterpene Acids Activating the G Protein-Coupled Bile Acid Receptor TGR5 by Angela Ladurner, Martin Zehl, Martin Zehl, Martin Zehl, Ulrike Grienke, Christoph Hofstadler, Nadina Faur, Fátima C. Pereira, David Berry, Verena M. Dirsch, Judith M. Rollinger

Connect to this object online.

Autophagy-related biomarkers in preeclampsia: the underlying mechanism, correlation to the immune microenvironment and drug screening by Rui Wan, Peng Yao, Yuxiu Wang, Lele Zhang, Wei Guo, Meiying Du, Yu Wang, Wenbiao Shi, Weili Li

Connect to this object online.

PROVIDER-LEVEL VARIATION IN NOVEL CARDIOVASCULAR MEDICATION PRESCRIPTION AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE AND CORONARY ARTERY DISEASE IN THE VETERANS AFFAIRS SYSTEM by Taufiq Salahuddin, MD

Connect to this object online.

Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study by Diego Bellido, MD, PhD, Pablo Abellán, MD, PhD, José Manuel Ruiz Palomar, MD, Rogelio Álvarez Sintes, MD, Andreu Nubiolae, MD, Virginia Bellido, MD, PhD, Gracia Romero, PhD

Connect to this object online.

PRESCRIBING PRACTICES OF CARDIOPROTECTIVE ANTI-DIABETIC MEDICATIONS IN MARGINALIZED PATIENTS by Raheel Khan, DO, Arham Pasha, MD, Angela Khidhir, DO, Toluwanimi Aladesua, MD, Jawdat Mustafa, MD, Gregory D. Gudleski, PhD, Smita Bakhai, MD

Connect to this object online.

Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK by Belinda Trachsel, Giulia Valpreda, Alexandra Lutz, Roger Schibli, Linjing Mu, Martin Béhé

Connect to this object online.

Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy by Jason M. Tonne, Toshie Sakuma, Michael C. Deeds, Miguel Munoz-Gomez, Michael A. Barry, Yogish C. Kudva, Yasuhiro Ikeda

Connect to this object online.

PPARα and PPARβ/δ are negatively correlated with proinflammatory markers in leukocytes of an obese pediatric population by Karina Vargas-Sánchez, Laura Vargas, Yenny Urrutia, Iván Beltrán, Ana Beatriz Rossi, Hernán Yupanqui Lozano, Jorge Guarín, Monica Losada-Barragán

Connect to this object online.

Clinical and radiographic variables related to implants with simultaneous grafts among type 2 diabetic patients treated with different hypoglycemic medications: a retrospective stu... by Shaojie Shi, Feng Ding, Xiangdong Liu, Lei Wang, Xingxing Wang, Sijia Zhang, Guoqiang Zhao, Yingliang Song

Connect to this object online.

Clinical potential of treatment with semaglutide in type 2 diabetes patients by Michael E Røder

Connect to this object online.

The prevalence of cardiovascular diseases, chronic kidney disease, and obesity in patients with type 2 diabetes mellitus and the description of concurrent treatments: A two-center... by Omar A. Alshaya, Ghazwa B. Korayem, Munirah Alghwainm, Wed Alyami, Albandari Alotaibi, Majed S. Alyami, Omar A. Almohammed

Connect to this object online.

Assessment of antidiabetic potential and phytochemical profiling of Rhazya stricta root extracts by Rashid Mahmood, Waqas Khan Kayani, Tanveer Ahmed, Farnaz Malik, Shahzad Hussain, Muhammad Ashfaq, Hussain Ali, Samina Rubnawaz, Brian D. Green, Danielle Calderwood, Owen Kenny, Gerardo A. Rivera, Bushra Mirza, Faiza Rasheed

Connect to this object online.

The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE−/− mice by blocking monocyte/macrophage activation by Florian Kahles, Ana Liberman, Constantin Halim, Matthias Rau, Julia Möllmann, Robert Werner Mertens, Marcia Rückbeil, Irmgard Diepolder, Benedikt Walla, Sebastian Diebold, Mathias Burgmaier, Corinna Lebherz, Nikolaus Marx, Michael Lehrke

Connect to this object online.

Economic analysis of Lixisenatide in Diabetes Mellitus Type 2 by A. S. Kolbin, A. A. Mosikyan, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, W. Zhao

Connect to this object online.

Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetesResearch in context by Luis A. Rodriguez, Holly Finertie, Romain S. Neugebauer, Bennett Gosiker, Tainayah W. Thomas, Andrew J. Karter, Lisa K. Gilliam, Caryn Oshiro, Jaejin An, Gregg Simonson, Andrea E. Cassidy-Bushrow, Sarah Dombrowski, Margaret Nolan, Patrick J. O'Connor, Julie A. Schmittdiel

Connect to this object online.

Impact of Initiating a GLP1 Agonist and/or SGLT2 Inhibitor Therapy on De-Escalation and Discontinuation of Insulin and Diabetes Control When Managed by an Interprofessional Collabo... by Megan Champion, Gabriel Wills Avila, Angelica E. Garcia, Faviola M. Álvarez Delgado, Connie A. Valdez

Connect to this object online.